Report Detail
Global (United States, European Union and China) Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Research Report 2019-2025
- RnM3687542 |
- 21 August, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and are used in the treatment of type 2 diabetes.
In 2019, the market size of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors.
This report studies the global market size of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Sanofi
Takeda
Eli Lilly
Merck
Novo Nordisk
Bristol-Myers Squibb
Pfizer
AstraZeneca
GlaxoSmithKline
Boehringer Ingelheim
Market Segment by Product Type
Nesina
Tradjenta
Onglyza
Januvia
Others
Market Segment by Application
Type 2 Diabetes
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Dipeptidyl Peptidase-4 (DPP-4) Inhibitors manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Nesina
- 1.3.3 Tradjenta
- 1.3.4 Onglyza
- 1.3.5 Januvia
- 1.3.6 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share by Application (2019-2025)
- 1.4.2 Type 2 Diabetes
- 1.4.3 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size
- 2.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue 2014-2025
- 2.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales 2014-2025
- 2.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Growth Rate by Regions
- 2.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Regions 2014-2019
- 2.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Manufacturers
- 3.1.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Manufacturers 2014-2019
- 3.1.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Manufacturers (2014-2019)
- 3.2.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Concentration Ratio (CR5 and HHI)
- 3.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Manufacturers
- 3.4 Key Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market
- 3.6 Key Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Nesina Sales and Revenue (2014-2019)
- 4.1.2 Tradjenta Sales and Revenue (2014-2019)
- 4.1.3 Onglyza Sales and Revenue (2014-2019)
- 4.1.4 Januvia Sales and Revenue (2014-2019)
- 4.1.5 Others Sales and Revenue (2014-2019)
- 4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type
- 4.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type
- 4.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application
6 United States
- 6.1 United States Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Breakdown Data by Company
- 6.2 United States Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Breakdown Data by Type
- 6.3 United States Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Breakdown Data by Application
7 European Union
- 7.1 European Union Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Breakdown Data by Company
- 7.2 European Union Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Breakdown Data by Type
- 7.3 European Union Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Breakdown Data by Application
8 China
- 8.1 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Breakdown Data by Company
- 8.2 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Breakdown Data by Type
- 8.3 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Breakdown Data by Company
- 9.2 Rest of World Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Breakdown Data by Type
- 9.3 Rest of World Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Breakdown Data by Application
- 9.4 Rest of World Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Breakdown Data by Countries
- 9.4.1 Rest of World Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Countries
- 9.4.2 Rest of World Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Sanofi
- 10.1.1 Sanofi Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
- 10.1.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Introduction
- 10.1.5 Sanofi Recent Development
- 10.2 Takeda
- 10.2.1 Takeda Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
- 10.2.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Introduction
- 10.2.5 Takeda Recent Development
- 10.3 Eli Lilly
- 10.3.1 Eli Lilly Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
- 10.3.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Introduction
- 10.3.5 Eli Lilly Recent Development
- 10.4 Merck
- 10.4.1 Merck Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
- 10.4.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Introduction
- 10.4.5 Merck Recent Development
- 10.5 Novo Nordisk
- 10.5.1 Novo Nordisk Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
- 10.5.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Introduction
- 10.5.5 Novo Nordisk Recent Development
- 10.6 Bristol-Myers Squibb
- 10.6.1 Bristol-Myers Squibb Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
- 10.6.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Introduction
- 10.6.5 Bristol-Myers Squibb Recent Development
- 10.7 Pfizer
- 10.7.1 Pfizer Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
- 10.7.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Introduction
- 10.7.5 Pfizer Recent Development
- 10.8 AstraZeneca
- 10.8.1 AstraZeneca Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
- 10.8.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Introduction
- 10.8.5 AstraZeneca Recent Development
- 10.9 GlaxoSmithKline
- 10.9.1 GlaxoSmithKline Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
- 10.9.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Introduction
- 10.9.5 GlaxoSmithKline Recent Development
- 10.10 Boehringer Ingelheim
- 10.10.1 Boehringer Ingelheim Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
- 10.10.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Introduction
- 10.10.5 Boehringer Ingelheim Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Channels
- 11.2.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors
- 11.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customers
12 Market Forecast
- 12.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue Forecast 2019-2025
- 12.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Type
- 12.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Application
- 12.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Forecast by Regions
- 12.4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Regions 2019-2025
- 12.4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Dipeptidyl Peptidase-4 (DPP-4) Inhibitors. Industry analysis & Market Report on Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is a syndicated market report, published as Global (United States, European Union and China) Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
